Live Breaking News & Updates on Launch Readiness Activities

Stay updated with breaking news from Launch readiness activities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cytokinetics Reports First Quarter 2022 Financial Results

Initial Data from REDWOOD-HCM OLE, the Open Label Extension Study of Aficamten, to be Presented at Heart Failure 2022 on May 23, 2022 Continued Launch. ....

United States , Arthurl Bloomfield , Omecamtiv Mecarbil , Johnt Henderson , Roberta Harrington , Roberti Blum , Skeletal Muscle Program , American Heart Association , York Heart Association , Department Of Medicine , Clinical Development , National Organization For Rare Disorders , Ongoing Research , American College Of Cardiology , Drug Administration , Cytokinetics Incorporated Nasdaq , Cytokinetics Communications Fellowship , Stanford University , European Organisation For Rare Diseases , Initial Data , Open Label Extension Study , Heart Failure , Launch Readiness Activities , Commercial Infrastructure , Cytokinetic President , Chief Executive ,